Equitable access to high-cost pharmaceuticals

March 14, 2018, University of Huddersfield
Professor Zaheer Babar's book. Credit: University of Huddersfield

Access to the best medicine has been enshrined as a human right. But many healthcare systems are already spending half of their budgets on drugs, while ageing populations in countries such as the UK are creating increased demand for high-cost treatment. So how can that access be made affordable? A new book edited by a University of Huddersfield professor explores the issue.

Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare at the University's Department of Pharmacy. He is globally recognised for his research in pharmaceutical policy and practice. His latest book, which has contributions from almost 30 experts around the world, is the 238-page Equitable Access to High-Cost Pharmaceuticals.

It begins with an overview - one of the chapters co-authored by Professor Babar himself - and subsequent chapters examine the issue of high cost medicines in a wide variety of countries, including England, Wales, New Zealand, Australia, Portugal and Europe as a whole. The emphasis of the book is on higher income countries, although there is also a chapter on in Africa.

"According to the UN, to medicine is a , like access to water or sanitation. So we don't need to treat it like other commodities, and that's where the tension arises," said Professor Babar.

"In some countries, 50 per cent of the health budget is going on high-cost drugs such as anti-cancer , drugs for immunological disorders, blood disorders or rheumatoid arthritis, for example. Who has the responsibility for making these medicines affordable?"

The new book, by analysing the solutions developed in a wide range of countries, will be useful for funding agencies and researchers around the world, enabling them to make comparisons, said Professor Babar.

"The issue is going to be more complex in the future, because people are living longer, meaning they will have more serious illness. So funding of high cost medicines, taking the biggest chunk of health budgets, is going to be more crucial."

Professor Babar describes the newly-published Equitable Access to High-Cost Pharmaceuticals as an exercise in documenting current practice, establishing a baseline. A follow-up book - now in the planning stage - will offer solutions and recommendations.

But among the issues explored in the current book is the funding and reimbursement of . New models are needed, said Professor Babar.

"The pharmacy industry is charging so much because it argues that it is investing a lot in R&D. But there is a lot of public money involved in drug development - through universities for example - so the public is effectively paying twice."

This could lead to a case for the price of drugs to be delinked from the cost of their development, said Professor Babar. The new book has chapters that explore issues such as and universal access to essential medicines.

Explore further: Challenges to equitable access to medicines

More information: www.elsevier.com/books/equitab … ar/978-0-12-811945-7

Related Stories

Challenges to equitable access to medicines

June 11, 2014
(Medical Xpress)—Access to medicines by vulnerable groups in the community, increasing medicine costs, and the demand for new medicines are some of the challenges identified in an independent study of priority medicine ...

Asthma medicines a struggle for many countries

October 16, 2013
(Medical Xpress)—The availability, pricing and affordability of three essential asthma medicines varies greatly according to a new study of 52 low-and middle-income countries

Funding a set of essential medicines for low- and middle-income countries

November 8, 2016
As the world moves toward universal health coverage, the question arises: How can governments ensure equitable access to essential medicines in low- and middle-income countries?

Tackling the global post-code lottery: new research explores how law can help tackle health epidemics

November 23, 2017
Research from the University of Warwick is set to improve global health by helping lawyers to think more strategically about the ways in which the law can be used to improve access to life-saving medicines.

Study reveals inequality in access to treatment in Asia

November 20, 2017
The European Society for Medical Oncology (ESMO) opened its 3rd ESMO Asia Congress today, once again in Singapore, attracting close to 3000 regional and international cancer doctors with leading researchers and experts to ...

Universal public coverage of essential medicines would improve access, save billions

February 27, 2017
Publicly funding essential medicines could cover the cost of nearly half of all prescriptions in Canada, removing financial barriers for Canadians while saving $3 billion per year.

Recommended for you

Patient-centered visual aid helps physicians discuss risks, treatments with parents

September 21, 2018
A series of illustrations and charts designed as decision aids for parents of children with minor head injuries helped them communicate with emergency medicine physicians and make informed decisions about their child's care, ...

Alcohol responsible for one in 20 deaths worldwide: WHO

September 21, 2018
Alcohol kills three million people worldwide each year—more than AIDS, violence and road accidents combined, the World Health Organization said Friday, adding that men are particularly at risk.

It's not just for kids—even adults appear to benefit from a regular bedtime

September 21, 2018
Sufficient sleep has been proven to help keep the body healthy and the mind sharp. But it's not just an issue of logging at least seven hours of Z's.

Most nations falling short of UN targets to cut premature deaths from chronic diseases

September 21, 2018
People in the UK, US and China have a higher risk of dying early from conditions like cancer, heart disease and stroke than people in Italy, France, South Korea and Australia.

Smart pills dumb down medical care, experts warn

September 21, 2018
Enthusiasm for an emerging digital health tool, the smart pill, is on the rise but researchers at the University of Illinois at Chicago have published a paper in the American Journal of Bioethics that cautions health care ...

China's doctor shortage prompts rush for AI health care

September 20, 2018
Qu Jianguo, 64, had a futuristic medical visit in Shanghai as he put his wrist through an automated pulse-taking machine and received the result within two minutes on a mobile phone—without a doctor present.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.